Background: Repeated freezing and thawing of plasma (or serum) may influence the stability of plasma (or serum) constituents. Despite the alarming warnings from commercial manuals that freeze-thaw cycles affect the stability of hormones in plasma (or serum), surprisingly little, consistent information about this concept is available in literature.
Introduction
Repeated freezing and thawing of plasma may influence the stability of plasma (or serum) constituents. Results of analyses performed in plasma samples exposed to repeated freeze-thaw cycles might therefore differ from analyses performed in fresh, or only once thawed samples. Nowadays targeted laboratory diagnostics results in a reduction of initial blood sampling and laboratory requests. If necessary, add-ons are requested and thus valid information about freezethaw stability of plasma constituents is essential. Manuals of commercial assays for endocrine parameters often report limited freeze-thaw stability, despite lacking or inconsistent evidence. We investigated the influence of repeated freeze-thaw cycles on 15 endocrine parameters that are regularly requested in our laboratory and of which (consistent) information on freeze-thaw stability is lacking.
Methods
Ten volunteers (3 male, 7 female; age range 28-64 years, not fasted) donated 50 mL blood. The local Medical Ethical Committee of the Academic Medical Center confirmed that ethical approval was not required. Venous blood was collected in Vacutainer TM blood collection tubes (Becton Dickinson, Franklin Lakes, NJ, USA) with K 2 EDTA for adrenocorticotropic hormone (ACTH), osteocalcin and plasma renin activity (PRA) analyses, lithium heparin for a-subunits, cortisol binding globulin (CBG), glucagon, inhibin B, free thyroxine (fT4), total thyroxine (TT4), total triiodothyronine (TT3), reverse triiodothyronine (rT3), thyroxine-binding globulin (TBG), and thyroid stimulating hormone (TSH) analysis, and blank serum tubes for chromogranin A and thyroglobulin (TG). EDTA blood for ACTH measurements was stored on ice and quickly centrifuged (1559 g, 3000 r/min, 4 C) and aliquoted. All other tubes were quickly centrifuged at room temperature (RT) (1559 g, 3000 r/min). Serum or plasma was aliquoted into polystyrene tubes (within 2 h) and stored at À20 C until further analysis (T0). Samples were thawed at RT during 1 h and frozen again at À20 C. This procedure was performed in respective aliquots once (T1), twice (T2) or three (T3) times on consecutive days. In addition, the 24 h-stability of hormones on ice in a transport box was evaluated to mimic transport conditions between laboratories. Frozen aliquoted samples were placed on an icepack in a Styrofoam transport box, which was left at RT for 24 h (T24h). After 24 h samples were frozen at À20 C until further analysis.
ACTH was determined with a chemiluminescent immunometric assay (Immulite 2000, Siemens, Los Angeles, USA, interassay variation (CV) 9%). Chromogranin A (CgA II) was determined by TRACE technology on a Kryptor Compact Plus analyser (Thermofisher, Hennigsdorf, Germany, CV 2%). fT4 was determined using a fluoroimmunoassay and TSH using a fluoroimmunometric assay (Delfia, PerkinElmer Life and Analytical Sciences, Turku, Finland, CVs 4 and 6%). TT4, TT3 and rT3 were determined by an in-house 125À I RIA (CVs 5%, 8% and 9%). 1 
Results and discussion
PRA increased following repeated freeze-thaw cycles; after two and three freeze-thaw cycles, PRA was increased vs. baseline (P ¼ 0.0076) ( Table 1) . ACTH concentrations were reduced vs. baseline after three additional freeze-thaw cycles (P ¼ 0.0008). Frozen aliquots that were placed on icepacks in a Styrofoam box for 24 h had reduced ACTH (P ¼ 0.0009), TSH (P ¼ 0.0225), TBG (P ¼ 0.0205) and osteocalcin concentrations (P ¼ 0.0003) and increased PRA (P ¼ 0.047) compared to baseline. Results for all other endocrine parameters tested were not different from baseline. Thus, up to three freeze-thaw cycles did not influence a-subunits, CBG, fT4, glucagon, inhibin B and TG concentrations, despite alarming notifications in brochures of these assays. Chromogranin A, rT3, TT4 and TT3 were also not affected. Increased PRA following repeated freeze-thaw cycling and upon storage on ice in a Styrofoam box for 24 h can be explained by unfolding of the prorenin segment and its cleavage by proteases (e.g. cryoactivation) at temperatures between À5 C and 4 C. 3 The observed increases of PRA were larger than the interassay variation. PRA analysis thus enquires fresh or only once frozen samples. ACTH is notorious for its instability due to proteolytic degradation; however, effects of multiple freeze-thaw cycles on ACTH stability have not been frequently described. Given the interassay variation, the observed changes in ACTH concentrations should be considered of minimal clinical relevance. Data on freeze-thaw stability of osteocalcin in literature is inconsistent. This is probably due to assay differences as some assays measure osteocalcin fragments and others do not. 4 We used an ELISA measuring total osteocalcin and observed no changes in osteocalcin up to three freeze-thaw cycles, and a small, but significant, reduction in osteocalcin upon storage on ice in a Styrofoam box for 24 h. For TBG and TSH, we also found decreases upon storage on ice in a Styrofoam box for 24 h. Stability of TBG during different storage conditions has not been described in literature before. TSH stability was demonstrated at several storage conditions, 5,6 however, TSH deterioration due to long-term cold storage has also been suggested. 7 In view of interassay variations, the observed changes in osteocalcin, TBG and TSH were considered of minimal (clinical) relevance.
Conclusion
For most analysed endocrine parameters, we found no effects of multiple freeze-thaw cycles despite alarming notifications in assay manuals. PRA was the only endocrine parameter that showed significant and relevant changes. Note: Data were normally distributed except for chromogranin A and osteocalcin due to extreme values from two subjects. These values were not excluded because relative changes were not affected. For inhibin B: n ¼ 6, because four subjects had values below LoQ (<10 ng/L). For PRA: n ¼ 7, because two subjects had PRA values below LoQ (<0.3 g Angiotensin 1/L/h) and one subject above the assays' upper limit (>10 g Angiotensin 1/L/ h). T2 data for TBG and TG are missing due to erroneous aliquot distribution. *P < 0.05.
